Advanced search
Publication Cover
Expert Opinion on Therapeutic Targets Volume 12, 2008 - Issue 8
Submit an article Journal homepage
865
Views
58
CrossRef citations to date
0
Altmetric
Reviews

MK2: a novel molecular target for anti-inflammatory therapy

Senthil Duraisamy Senior Research Scientist Ranbaxy Research Laboratories, New Drug Discovery Research, Department of Pharmacology, Plot No-20, Sector-18, Gurgaon-122001-Haryana, India +91 124 2342001 10, ext. 5265; +91 124 2343544; [email protected]
, PhD,
Malini Bajpai Senior Research Scientist Ranbaxy Research Laboratories, New Drug Discovery Research, Department of Pharmacology, Plot No-20, Sector-18, Gurgaon-122001-Haryana, India +91 124 2342001 10, ext. 5265; +91 124 2343544; [email protected]
, PhD,
Usha Bughani Research Scientist Ranbaxy Research Laboratories, New Drug Discovery Research, Department of Pharmacology, Plot No-20, Sector-18, Gurgaon-122001-Haryana, India
, PhD,
Sunanda G Dastidar Associate Director Ranbaxy Research Laboratories, New Drug Discovery Research, Department of Pharmacology, Plot No-20, Sector-18, Gurgaon-122001-Haryana, India
, PhD,
Abhijit Ray Director Ranbaxy Research Laboratories, New Drug Discovery Research, Department of Pharmacology, Plot No-20, Sector-18, Gurgaon-122001-Haryana, India
, PhD &
Puneet Chopra Senior Research Scientist Ranbaxy Research Laboratories, New Drug Discovery Research, Department of Pharmacology, Plot No-20, Sector-18, Gurgaon-122001-Haryana, India +91 124 2342001 10, ext. 5265; +91 124 2343544; [email protected]
, PhD
Pages 921-936 | Published online: 12 Jul 2008

Bibliography

  • Shankar S, Handa R. Biological agents in rheumatoid arthritis. J Postgrad Med 2004;50(4):293-9
  • Peifer C, Wagner G, Laufer S. New approaches to the treatment of inflammatory disorders small molecule inhibitors of p38 MAP kinase. Curr Top Med Chem 2006;6(2):113-49
  • Cuenda A, Rousseau S. p38 MAP-kinases pathway regulation, function and role in human diseases. Biochim Biophys Acta 2007;1773(8):1358-75
  • Dambach DM. Potential adverse effects associated with inhibition of p38α/β MAP kinases. Curr Top Med Chem 2005;5(10):929-39
  • Mudgett JS, Ding J, Guh-Siesel L, et al. Essential role for p38α mitogen-activated protein kinase in placental angiogenesis. Proc Natl Acad Sci USA 2000;97(19):10454-9
  • Martín-Blanco E. p38 MAPK signalling cascades: ancient roles and new functions. Bioessays 2000;22(7):637-45
  • Kotlyarov A, Neininger A, Schubert C, et al. MAPKAP kinase 2 is essential for LPS-induced TNF-α biosynthesis. Nat Cell Biol 1999;1(2):94-7
  • Cobb MH, Goldsmith EJ. How MAP kinases are regulated. J Biol Chem 1995;25(1):7-9
  • Rouse J, Cohen P, Trigon S, et al. A novel kinase cascade triggered by stress and heat shock that stimulates MAPKAP kinase-2 and phosphorylation of the small heat shock proteins. Cell 1994;78:1027-37
  • Clifton AD, Young PR, Cohen P. A comparison of the substrate specificity of MAPKAP kinase-2 and MAPKAP kinase-3 and their activation by cytokines and cellular stress. FEBS Lett 1996;392:209-14
  • Engel K, Plath K, Gaestel M. The MAP kinase-activated protein kinase 2 contains a proline-rich SH3-binding domain. FEBS Lett 1993;336:143-7
  • Gaestel M. MAPKAP kinases – MKs – two's company, three's a crowd. Nat Rev Mol Cell Biol 2006;7(2):120-30
  • Plath K, Engel K, Schwedersky G, Gaestel M. Characterization of the proline-rich region of mouse MAPKAP kinase 2: influence on catalytic properties and binding to the c-abl SH3 domain in vitro. Biochem Biophys Res Commun 1994;203(2):1188-94
  • Lukas SM, Kroe RR, Wildeson J, et al. Catalysis and function of the p38α. MK2a signaling complex. Biochemistry 2004;43(31):9950-60
  • Engel K, Kotlyarov A, Gaestel M. Leptomycin B-sensitive nuclear export of MAPKAP kinase 2 is regulated by phosphorylation. EMBO J 1998;17(12):3363-71
  • Kotlyarov A, Yannoni Y, Fritz S, et al. Distinct cellular functions of MK2. Mol Cell Biol 2002;22(13):4827-35
  • Stokoe D, Campbell DG, Nakielny S, et al. MAPKAP kinase-2; a novel protein kinase activated by mitogen-activated protein kinase. EMBO J 1992;11(11):3985-94
  • Roux PP, Blenis, J. ERK and p38 MAPK-activated protein kinases: a family of protein kinases with diverse biological functions. Microbiol Mol Biol Rev 2004;68(2):1092-2172
  • Ben-Levy R, Hooper S, Wilson R, et al. Nuclear export of the stress-activated protein kinase p38 mediated by its substrate MAPKAP kinase-2. Curr Biol 1998;8(19):1049-57
  • Allen M, Svensson L, Roach M, et al. Deficiency of the stress kinase p38 results in embryonic lethality: characterization of the kinase dependence of stress responses of enzyme deficient embryonic stem cells. J Exp Med 2000;191:859-70
  • Ter Haar E, Prabhakar P, Liu X, Lepre C. Crystal structure of the p38α–MAPKAP kinase 2 heterodimer. J Biol Chem 2007;282:9733-9
  • White A, Pargellis CA, Studts JM, et al. Molecular basis of MAPK-activated protein kinase 2:p38 assembly. Proc Natl Acad Sci USA 2007;104:6353-8
  • Underwood KW, Parris KD, Federico E, et al. Catalytically active MAP KAP kinase 2 structures in complex with staurosporine and ADP reveal differences with the autoinhibited enzyme. Structure 2003;11:627-36
  • Hillig RC, Eberspaecher U, Monteclaro F, et al. Structural basis for a high affinity inhibitor bound to protein kinase MK2. J Mol Biol 2007;369:735-45
  • Komatsu S, Murai N, Totsukawa G, et al. Identification of MAPKAPK homolog (MAPKAPK-4) as a myosin II regulatory light-chain kinase in sea urchin egg extracts. Arch Biochem Biophys 1997;343(1):55-62
  • Larochelle S, Suter B. The Drosophila melanogaster homolog of the mammalian MAPK-activated protein kinase-2 (MAPKAPK-2) lacks a proline-rich N-terminus. Gene 1995;163(2):209-14
  • Lammer C, Wagerer S, Saffrich R, et al. The cdc25B phosphatase is essential for the G2/M phase transition in human cells. J Cell Sci 1998;111(16):2445-53
  • Reinhardt HC, Aslanian AS, Lees JA, Yaffe MB. p53-Deficient cells rely on ATM- and ATR-mediated checkpoint signaling through the p38MAPK/MK2 pathway for survival after DNA damage. Cancer cell 2007;11(2):175-89
  • Forrest A, Gabrielli B. Cdc25B activity is regulated by 14-3-3. Oncogene 2001;20(32):4393-401
  • Manke IA, Nguyen A, Lim D, et al. MAPKAP kinase-2 is a cell cycle checkpoint kinase that regulates the G2/M transition and S phase progression in response to UV irradiation. Mol Cell 2005;17(1):37-48
  • Weber HO, Ludwig RL, Morrison D, et al. HDM2 phosphorylation by MAPKAP kinase 2. Oncogene 2005;24(12):1965-72
  • Bulavin DV, Higashimoto Y, Popoff IJ, et al. Initiation of a G2/M checkpoint after ultraviolet radiation requires p38 kinase. Nature 2001;411(6833):102-7
  • Hegen M, Gaestel M, Nickerson-Nutter CL, et al. MAPKAP kinase 2-deficient mice are resistant to collagen-induced arthritis. J Immunol 2006;177(3):1913-17
  • Fleming RM, Harrington GM. What is the relationship between myocardial perfusion imaging and coronary artery disease risk factors and markers of inflammation? Angiology 2008;1:16-25
  • Monaco C, Andreakos E, Kiriakidis S, et al. T-cell-mediated signalling in immune, inflammatory and angiogenic processes: the cascade of events leading to inflammatory diseases [review]. Curr Drug Targets Inflamm Allergy 2004;3(1):35-42
  • Saklatvala J. The p38 MAP kinase pathway as a therapeutic target in inflammatory disease. Curr Opin Pharmacol 2004;4(4):372-7
  • Revesz L, Blum E, Di Padova FE, et al. Novel p38 inhibitors with potent oral efficacy in several models of rheumatoid arthritis. Bioorg Med Chem Lett 2004;4(13):3595-9
  • Clark AR, Dean JL, Saklatvala J. Post-transcriptional regulation of gene expression by mitogen-activated protein kinase p38. FEBS Lett 2003;546(1):37-44
  • Landry J, Lambert H, Zhou M, et al. Human HSP27 is phosphorylated at serines 78 and 82 by heat shock and mitogen-activated kinases that recognize the same amino acid motif as S6 kinase II. J Biol Chem 1992;267(2):794-803
  • Huang CK, Zhan L, Ai Y, Jongstra J. LSP1 is the major substrate for mitogen-activated protein kinase-activated protein kinase 2 in human neutrophils. J Biol Chem 1997;272(1):17-29
  • Hedges JC, Dechert MA, Yamboliev IA, M, et al. A role for p38(MAPK)/HSP27 pathway in smooth muscle cell migration. J Biol Chem 1999;274(34):24211-9
  • Coxon PY, Rane MJ, Uriarte S, et al. MAPK-activated protein kinase-2 participates in p38 MAPK-dependent and ERK-dependent functions in human neutrophils. Cell Signal 2003;15(11):993-1001
  • Zheng C, Lin Z, Zhao ZJ, et al. MAPK-activated protein kinase-2 (MK2)-mediated formation and phosphorylation-regulated dissociation of the signal complex consisting of p38, MK2, Akt, and Hsp27. J Biol Chem 2006;281(48):37215-26
  • Rousseau S, Houle F, Kotanides H, et al. Vascular endothelial growth factor (VEGF)-driven actin-based motility is mediated by VEGFR2 and requires concerted activation of stress-activated protein kinase 2 (SAPK2/p38) and geldanamycin-sensitive phosphorylation of focal adhesion kinase. J Biol Chem 2000;275(14):10661-72
  • Benndorf R, Hayess K, Ryazantsev S, et al. Phosphorylation and supramolecular organization of murine small heat shock protein HSP25 abolish its actin polymerization-inhibiting activity. J Biol Chem 1994;269(32):20780-4
  • Kobayashi M, Nishita M, Mishima T, et al. MAPKAPK-2-mediated LIM-kinase activation is critical for VEGF-induced actin remodeling and cell migration. EMBO J 2006;25(4):713-26
  • Schwartz SM. Smooth muscle migration in atherosclerosis and restenosis [review]. J Clin Invest 1997;100(11 Suppl):S87-89
  • Korpelainen EI, Alitalo K. Signaling angiogenesis and lymphangiogenesis [review]. Curr Opin Cell Biol 1998;10(2):159-64
  • Chrestensen CA, Schroeder MJ, Shabanowitz J, et al. MAPKAP kinase 2 phosphorylates tristetraprolin on in vivo sites including Ser178, a site required for 14-3-3 binding. J Biol Chem 2004;279(11):10176-84
  • Carballo E, Lai WS, Blackshear PJ. Feedback inhibition of macrophage tumor necrosis factor-α production by tristetraprolin. Science 1998;281(5379):1001-5
  • Hitti E, Iakovleva T, Brook M, et al. Mitogen-activated protein kinase-activated protein kinase 2 regulates tumor necrosis factor mRNA stability and translation mainly by altering tristetraprolin expression, stability, and binding to adenine/uridine-rich element. Mol Cell Biol 2006;26(6):2399-407
  • Ronkina N, Kotlyarov A, Dittrich-Breiholz O, et al. The mitogen-activated protein kinase (MAPK)-activated protein kinases MK2 and MK3 cooperate in stimulation of tumor necrosis factor biosynthesis and stabilization of p38 MAPK. Mol Cell Biol 2007;27(1):170-81
  • Zheng Sun, Sandeep Sood, Ning LI, et al. Involvement of the 5-lipoxygenase/leukotriene A4 hydrolase pathway in 7,12-dimethylbenz[a]anthracene (DMBA)-induced oral carcinogenesis in hamster cheek pouch, and inhibition of carcinogenesis by its inhibitors. Carcinogenesis 2006;27(9):1902-8
  • Werz O, Szellas D, Steinhilber, Radmark O. Arachidonic acid promotes phosphorylation of 5-lipoxygenase at Ser-271 by MAPK-activated protein kinase 2 (MK2). J Bio Chem 2002;277(17):14793-800
  • Kotlyarov A, Gaestel M. Is MK2 (mitogen-activated protein kinase-activated protein kinase 2) the key for understanding post-transcriptional regulation of gene expression? Biochem Soc Trans 2002;30(6):959-63
  • Tietz AB, Malo A, Diebold J, et al. Gene deletion of MK2 inhibits TNF-α and IL-6 and protects against cerulein-induced pancreatitis. Am J Physiol Gastrointest Liver Physiol 2006;290(6):1298-306
  • Thuraisingam T, Xu YZ, Moisan J, et al. Distinct role of MAPKAPK-2 in the regulation of TNF gene expression by Toll-like receptor 7 and 9 ligands. Mol Immunol 2007;44(14):3482-91
  • Lin FY, Chen YH, Tasi JS, et al. Endotoxin induces toll-like receptor 4 expression in vascular smooth muscle cells via NADPH oxidase activation and mitogen-activated protein kinase signaling pathways. Arterioscler Thromb Vasc Biol 2006;26(12):2630-7
  • Rajasingh J, Bord E, Luedemann C, et al. IL-10-induced TNF-alpha mRNA destabilization is mediated via IL-10 suppression of p38 MAP kinase activation and inhibition of HuR expression. FASEB J 2006;20(12):2112-4
  • Gorska MM, Liang Q, Stafford SJ, et al. MK2 controls the level of negative feedback in the NF-κB pathway and is essential for vascular permeability and airway inflammation. J Exp Med 2007;204(7):1637-52
  • Wang X, Khaleque MA, Zhao MJ, Zhong R, et al. Phosphorylation of HSF1 by MAPK-activated protein kinase 2 on serine 121, inhibits transcriptional activity and promotes HSP90 binding. J Biol Chem 2006;281(2):782-91
  • Almholt DL, Loechel F, Nielsen SJ, et al. Nuclear export inhibitors and kinase inhibitors identified using a MAPK-activated protein kinase 2 redistribution screens. Assay Drug Dev Technol 2004;2(1):7-20
  • Shi Y, Kotlyarov A, Laabeta K, et al. Elimination of protein kinase MK5/PRAK activity by targeted homologous recombination. Mol Cell Biol 2003;23(21):7732-41
  • Lehner MD, Schwoebel F, Kotlyarov A, et al. Mitogen-activated protein kinase-activated protein kinase 2-deficient mice show increased susceptibility to Listeria monocytogenes infection. J Immunol 2002;168(9):4667-73
  • Morel F, Doussiere J, Vignais PV. The superoxide-generating oxidase of phagocytic cells. Physiological, molecular and pathological aspects [review]. Eur J Biochem 1991;201(3):523-46
  • Iles KE, Forman HJ. Macrophage signaling and respiratory burst [review]. Immunol Res 2002;26(1-3):95-105
  • Hoyal CR, Girón-Calle J, Forman HJ. The alveolar macrophage as a model of calcium signaling in oxidative stress. J Toxicol Environ Health B Crit Rev 1998;1(2):117-34
  • Firestein GS. Evolving concepts of rheumatoid arthritis. Nature 2003;423:356-61
  • Schett G, Tohidast-Akrad M, Smolen JS, et al. Activation, differential localization, and regulation of the stress-activated protein kinases, extracellular signal-regulated kinase, c-JUN N-terminal kinase, and p38 mitogen-activated protein kinase, in synovial tissue and cells in rheumatoid arthritis. Arthritis Rheum 2000;43(11):2501-12
  • Mclay LM, Halley F, Souness JE, et al. The discovery of RPR 200765A, a p38 MAP kinase inhibitor displaying a good oral anti-arthritic efficacy. Bioorg Med Chem 2001;9(2):537-54
  • Pargellis C, Regan J. Inhibitors of p38 mitogen-activated protein kinase for the treatment of rheumatoid arthritis. Curr Opin Investig Drugs 2003;4(5):566-71
  • Kumar S, Boehm J, Lee JC. p38 MAP kinases: key signalling molecules as therapeutic targets for inflammatory diseases. Nat Rev Drug Discov 2003;2(9):717-26
  • Schnyder B, Meunier PC, Car BD. Inhibition of kinases impairs neutrophil activation and killing of Staphylococcus aureus. Biochem J 1998;331(2):489-95
  • Van Den Blink B, Juffermans NP, Ten Hove T, et al. p38 mitogen-activated protein kinase inhibition increases cytokine release by macrophages in vitro and during infection in vivo. J Immunol 2001;166(1):582-7
  • Olsen NJ, Stein CM. New drugs for rheumatoid arthritis. N Engl J Med 2004;350(21):2167-79
  • Hannigan MO, Zhan L, Ai Y, et al. Abnormal migration phenotype of mitogen-activated protein kinase-activated protein kinase 2-/- neutrophils in Zigmond chambers containing formyl-methionyl-leucyl-phenylalanine gradients. J Immunol 2001;167(7):3953-61
  • Mcgeer EG, Mcgeer PL. Inflammatory processes in Alzheimer's disease. Prog Neuropsychopharmacol Biol Psychiatry 2003;27(5):741-9
  • Mcgeer EG, Yasojima K, Schwab C, Mcgeer PL. The pentraxins: possible role in Alzheimer's disease and other innate inflammatory diseases. Neurobiol Aging 2001;22(6):843-8
  • Eikelenboom P, Bate C, Van Gool WA, et al. Neuroinflammation in Alzheimer's disease and prion disease. Glia 2002;40(2):232-9
  • Rogers J, Strohmeyer R, Kovelowski CJ, Li R. Microglia and inflammatory mechanisms in the clearance of amyloid β peptide. Glia 2002;40(2):260-9
  • Diemel LT, Copelman CA, Cuzner ML. Macrophages in CNS remyelination: friend or foe? Neurochem Res 1998;23(3):341-7
  • Giulian D. Microglia and the immune pathology of Alzheimer disease. Am J Hum Genet 1999;65(1):13-8
  • Kaul M, Garden GA, Lipton SA. Pathways to neuronal injury and apoptosis in HIV-associated dementia. Nature 2001;410(6831):988-94
  • Sugino T, Nozaki K, Takagi Y, et al. Activation of mitogen-activated protein kinases after transient forebrain ischemia in gerbil hippocampus. J Neurosci 2000;20(12):4506-14
  • Irving EA, Barone FC, Reith AD, et al. Differential activation of MAPK/ERK and p38/SAPK in neurones and glia following focal cerebral ischaemia in the rat. Brain Res Mol Brain Res 2000;77(1):65-75
  • Wang X, Xu L, Wang H, et al. Mitogen-activated protein kinase-activated protein (MAPKAP) kinase 2 deficiency protects brain from ischemic injury in mice. J Biol Chem 2002;277(46):43968-72
  • Giovannini MG, Scali C, Prosperi C, et al. β-amyloid-induced inflammation and cholinergic hypofunction in the rat brain in vivo: involvement of the p38MAPK pathway. Neurobiol Dis 2002;11(2):257-74
  • Koistinaho M, Kettunen MI, Goldsteins G, et al. β-amyloid precursor protein transgenic mice that harbor diffuse Aβ deposits but do not form plaques show increased ischemic vulnerability: role of inflammation. Proc Natl Acad Sci USA 2002;99(3):1610-5
  • Atzori C, Ghetti B, Piva R, et al. Activation of the JNK/p38 pathway occurs in diseases characterized by tau protein pathology and is related to tau phosphorylation but not to apoptosis. J Neuropathol Exp Neurol 2001;60(12):1190-7
  • Culbert AA, Skaper SD, Howlett DR, et al. MAPK-activated protein kinase 2 deficiency in microglia inhibits pro-inflammatory mediator release and resultant neurotoxicity. Relevance to neuroinflammation in a transgenic mouse model of Alzheimer disease. J Biol Chem 2006;281(33):23658-67
  • Ross R. Atherosclerosis–an inflammatory disease. N Engl J Med 1999;340(2):115-26
  • Libby P. Inflammation in atherosclerosis. Nature 2002;420(6917):868-74
  • Moore KJ, Freeman MW. Scavenger receptors in atherosclerosis: beyond lipid uptake. Arterioscler Thromb Vasc Biol 2006;26(8):1702-11
  • Cybulsky MI, Iiyama K, Li H, et al. A major role for VCAM-1, but not ICAM-1, in early atherosclerosis. J Clin Invest 2001;107(10):1255-62
  • Gu L, Okada Y, Clinton SK, et al. Absence of monocyte chemoattractant protein-1 reduces atherosclerosis in low density lipoprotein receptor-deficient mice. Mol Cell 1998;2(2):275-81
  • Hartwell LH, Kastan MB. Cell cycle control and cancer. Science 1994;266(5192):1821-8
  • Zhou BB, Elledge SJ. The DNA damage response: putting checkpoints in perspective. Nature 2000;408(6811):433-9
  • Harris SL, Levine AJ. The p53 pathway: positive and negative feedback loops. Oncogene 2005;24(17):2899-908
  • Vogelstein B, Lane D, Levine AJ. Surfing the p53 network. Nature 2000;408(6810):307-10
  • Fridman JS, Lowe SW. Control of apoptosis by p53. Oncogene 2003;22(56):9030-40
  • Vousden KH, Lu X. Live or let die: the cell's response to p53. Nat Rev Cancer 2002;2(8):594-604
  • Davis T, Bagley MC, Dix MC, et al. Synthesis and in vivo activity of MK2 and MK2 substrate-selective p38α(MAPK) inhibitors in Werner syndrome cells. Bioorg Med Chem Lett 2007;17(24):6832-5
  • Wu JP, Wang J, Abeywardane A, et al. The discovery of carboline analogs as potent MAPKAP-K2 inhibitors. Bioorg Med Chem Lett 2007;17(16):4664-9
  • Anderson DR, Meyers MJ, Vernier WF, et al. Pyrrolopyridine inhibitors of mitogen-activated protein kinase-activated protein kinase 2 (MK-2). J Med Chem 2007;50(11):2647-54
  • Anderson DR, Hegde S, Reinhard E, et al. Aminocyanopyridine inhibitors of mitogen activated protein kinase-activated protein kinase 2 (MK-2). Bioorg Med Chem Lett 2005;15(6):1587-90
  • Williams DE, Telliez JB, Liu J, et al. Meroterpenoid MAPKAP (MK2) inhibitors isolated from the indonesian marine sponge Acanthodendrilla sp. J Nat Prod 2004;67(12):2127-9

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.